Risk-adapted durations of hormone therapy combined with radiotherapy for prostate cancer
Combining androgen deprivation therapy (ADT) with definitive radiotherapy improves oncologic outcomes in localized and locally advanced prostate cancer; however, the optimal duration of ADT remains contested. We synthesized evidence from randomized trials, individual patient-level and net...
Guardat en:
| Autors principals: | , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Academia.edu Journals
2025-12-01
|
| Col·lecció: | Academia Oncology |
| Accés en línia: | https://www.academia.edu/145359422/Risk_adapted_durations_of_hormone_therapy_combined_with_radiotherapy_for_prostate_cancer |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
